Wednesday, September 18, 2013

Dr. Hudak's Delayed Diagnosis Story...

Sometimes it's PHDuring the past year, PHA has been developing an Early Diagnosis Campaign.  Titled "Sometimes It's PH", the campaign emerged from recent publications showing that over the past 20 years, despite the increased visibility for PH, there has been little if any reduction in the time from onset of symptoms to point of diagnosis.  With 9 FDA-approved treatments available - all over the past 17 years, eight during the past 12 years - earlier diagnosis is an essential pathway to improving patient care and extending life.  Dr. Lynn Brown at the University of Utah leads the campaign and writes a column that circulates quarterly to 40,000 physicians through PHA's medical journal, Advances in Pulmonary Hypertension.  Here is her newest column.  It is the compelling diagnosis story of Dr. Bonnie Hudak, a pulmonologist living with PH... 

Even a Physician with PH Can Be Misdiagnosed
By Lynn Brown, MD, Sometimes It's PH Campaign Chair

Dr. Hudak
Diagnosing PH is often so tricky that even a patient practicing pulmonology can experience delayed diagnosis.  That’s what happened to Bonnie Hudak, MD, a new member of the Sometimes it’s PH early diagnosis campaign’s Education Committee.  

Dr. Hudak is a pediatric pulmonologist at Nemours Children’s Clinic in Jacksonville, Fla., where she often treats asthma and cystic fibrosis but not PH.  Yet her path to diagnosis parallels that of many other PH patients, particularly middle-age women.

Dr. Hudak had long been treated for scleroderma and Reynaud’s disease.  Her rheumatologist knew of the association between PH and scleroderma.  Dr. Hudak maintained a healthy weight, exercising regularly while practicing medicine and raising children.  In her 40s, exercising became more difficult, but with her busy life, she says she paid this little attention. Then while hiking in 2004, Dr. Hudak discovered that at altitude she could not walk uphill.  

In Jacksonville she underwent an echo, an EKG and a chest x-ray.  Her doctor called the results “maybe slightly abnormal.” He was reassured and attributed her symptoms to perimenopause and deconditioning.  He reported that the cardiologist had considered her echo normal. “They were happy with normal, and I was, too,” Dr. Hudak says. 

Still, Saturday morning tennis games left her tired all weekend.  Once, at a neighborhood party, she was chatting with a cardiologist friend.  He told her firmly, “anyone with scleroderma and shortness of breath with exercise has PH unless proven otherwise.”  Two weeks later she was diagnosed by right-heart catheterization and referred to a PH specialty center.

Dr. Hudak’s experience at Mayo Clinic in Jacksonville under the care of Charles Burger, MD, highlights the importance of referral to specialty centers, a key element of the Sometimes it’s PH campaign. In a single day she received comprehensive testing including a more detailed echo which successfully measured tricuspid regurgitation velocity. Those administering these tests pursued results doggedly.  

Dr. Burger also admitted Dr. Hudak to the hospital for a right-heart catheterization that included a vasodilator challenge. Without that thorough procedure and all of the necessary testing, Dr. Hudak’s vasoreactive type of PH would not have been discovered. Dr. Hudak has stayed on nifedipine as her sole PH treatment and has improved from Class III to Class I.  She has also participated in a clinical trial.

In her practice Dr. Hudak now looks for a few more zebras among the horses.  She also looks more carefully at the data used to interpret studies. She would advise other physicians to be more vigilant with a patient who has an underlying condition associated with PH and to work up minimal symptoms that may be due to PH. She also suggests further evaluation if existing results don’t make sense in the clinical setting. 

Dr. Hudak’s experience illustrates that both patients and professionals must be more active in questioning the data and the decisions that drive diagnosis.  Her unique insights will be an asset as PHA works to enhance primary and specialty care professionals’ ability to diagnose and treat PH promptly and correctly.

To find out more about Sometimes it’s PH, visit the SometimesItsPH.org website.

Thursday, August 8, 2013

We continue to advance..

This blog was originally posted on August 8, two days after an FDA advisory panel voted their opinion on Riociguat.  It is now updated following the publication of an August 29 New England Journal of Medicine article  and September 2 presentation of new data on Macitentan at the European Society of Cardiology Conference in the Netherlands.  If approved, both drugs may offer additional treatment options for PAH (and Riociguat also for CTEPH). FDA decisions are expected by mid-October.


Tuesday, August 6 was a rare and important day...

A new drug for PAH and CTEPH was being reviewed by the Cardiovascular and Renal Drugs Advisory Committee of the FDA.  This is generally the final step before the FDA releases a decision on whether a drug is approved for release to market.


Thirteen years ago, I attended an FDA Advisory Committee meeting for the first time.  Actually, I attended two on two consecutive days.  The hearings were for what became the second and third drugs to be approved for PAH -  Tracleer and Remodulin.  It was an exciting two days.  The first treatment for PH - Flolan - had been approved in 1996 and five years later we were looking at a tripling of options for patients.

That was only the beginning.  Over the next decade, we would see another tripling...to nine treatments.  And, this week, we were looking at the strong possibility of a tenth.

Other changes, have taken place as well.  Unlike in those early hearings, three of the 11 panelists on the Committee - Drs. Stuart Rich, John Newman and Steven Kawut - are recognized experts i n the field.  Their contributions to the Committee conversation helped the entire panel understand the nuances and needs of this complex area of medicine.

During the public comments section of the meeting, I had the opportunity to read a letter that had been reviewed and approved by leadership of PHA's Scientific Leadership Council and our Board of Trustees.

While PHA NEVER directly recommends the approval of a drug - we believe it is the FDA's role to determine the safety and effectiveness of a treatment - we ALWAYS speak to the need of additional treatments for their individual and combination value to patients.

By 3:00pm following presentations by the new drug's sponsor (Bayer) and the FDA staff and many questions for both and much discussion, the Advisory Committee took their votes.  On the first, they recommended Riociguat's approval for treatment of pulmonary arterial hypertension. On the second they voted to recommend approval for Riociguat as the first treatment for Chronic Thromboembolic Pulmonary Hypertension (CTEPH) for patients who cannot undergo a pulmonary endarterectomy surgery to remove clots in their lungs, or for those who still have complications after having the procedure.

With nine treatments, PAH has as many or more treatments than all but two of the 7,000 rare diseases identified in the U.S.  Now, we will wait for the FDA to make the final decision on a tenth treatment by early October.


Here's a copy of the letter we sent to the FDA and delivered to the Advisory Committee:

August 2, 2013
Kristina A. Toliver, PharmD
Center for Drug Evalulation and Research
Food and Drug Administration
10903 New Hampshire Avenue
WO31-2417
Silver Spring, Maryland 20993-0002

Dear Dr. Toliver:

While there have been great advances in research and expanded treatment options for pulmonary arterial hypertension in recent years, I want to assure you that it is not enough.  Each week, we continue to send an average of 20 condolence cards to families of our members.  We continue to lose too many patients with this disease.  Different treatments work for different patients.

It is up to the FDA to judge the safety and efficacy of riociguat.  However, we at the Pulmonary Hypertension Association want you to know that, should this drug be deemed effective, the need is there for PAH where it will be a valuable addition in the arsenal of therapies. Additionally, for our patients with CTEPH who are not candidates for surgery or have post-operative pulmonary hypertension, we are excited that, if approved, riociguat will be a valuable therapeutic option. 

Sincerely,


Rino Aldrighetti
President and CEO

Wednesday, August 7, 2013

The Power of Teamwork: the PHPN Symposium

Ten years ago, PHA hosted the first PH Professional Network (PHPN) Symposium.

PHPN was a young group then.  Members were mostly nurses working in the PH field and they wanted to build professionalism in what was then a much smaller field.   They wanted to share their experiences and knowledge and help integrate young medical professionals entering the field more rapidly into a community that could do its best for patients.

So, in 2003 – on very short notice – PHA helped to organize a two day Symposium.  Sixty members attended and were excited about what took place.  Nurses and other medical professionals ran workshops.  I remember a very engaging medical debate in which leading physicians discussed major treatment issues.  And, of course, there was great networking where medical professionals broke down the isolation that still existed then in that smaller field.

The positive reaction led to a second Symposium two years later. Preparations for 2005 had a different feel and reality.  The Symposium moved from an event being done for the medical community to one being created by the medical community.  That made all the difference. A planning committee from PHPN took the reins, listened to their members and implemented.  Attendance grew by 400% to 250.

Each PHPN Symposium since then has continued to grow and add value.  Now the Symposium is a 3 day meeting that opens with an optional training and lobbying activity in Washington, DC.  As members visit Capitol Hill, they not only build their own skills in an area becoming more critical to health care but they are gaining knowledge they can take back home to share with their colleagues and patients.

As PHPN itself has grown to over 1,400 nurses, nurse practitioners, physician assistants, pharmacists, respiratory therapists, social workers and other non-MD medical professionals working in the PH field, new tracks have been added to create value for the broader group of medical professionals who now attend.


The 2013 PH Professional Network Symposium  (September 26-28 in Arlington, VA) remains a unique opportunity to learn from, and with, PH-treating colleagues.   If you are a non-MD medical professional working in this field, you won’t want to miss this upcoming opportunity!

Here a few of the 2013 Symposium Highlights:
·       28 diverse educational sessions featuring new topics, including exercise right heart catheterization, transitioning pediatric patients to adulthood and patient adherence.
·       Optional session tracks for respiratory therapists, pharmacists, social workers, and pediatric professionals.
·       Opportunity to earn up to 10.25 hours of continuing education credit.
·       Daily networking at meet-ups, receptions and in the Exhibit Hall with other PH-treating healthcare professionals from across the country.
·       Latest research presentations in the Poster Hall.
·       A visit to Capitol Hill to advocate for PH patients.

PHA is offering a discounted registration rate of $100 (a $150 savings!) to the first 250 PH-treating healthcare professionals who register for Symposium*. Don't delay — this special reduced pricing is going quickly!  Register now to take advantage of this special rate.


Tuesday, July 23, 2013

Ripples in the stream...

It's nice when recognition for PHA comes from others who recognize the work this organization does.

It's very special when that recognition comes from our own community.

Recently, I got the following e-mail message with the magic words, "your supporters have spoken"...




This message is brought to you by GreatNonprofits.org





Your supporters have spoken, and you've earned a spot on the 2013 Top Rated List! ""Pulmonary Hypertension Association"" is one of the first nonprofits to be honored this year and you are now listed as a winner on our leaderboard here. You'll be featured in our 2013 Holiday Giving Guide and on our 2013 Top-Rated List, distributed to media and corporate foundations.



All of us at PHA appreciated that people had taken - and are taking! - the time to tell Great NonProfits about what PHA has meant to them.  

But that wasn't all...  On the same day, Jaclyne Franciscone of LaRue PR wrote to our New York
Chapter executive director, Gina Parziale, to let her know that PHA has been included in the Charity Finds section of People StyleWatch. 

That's a big awareness-builder...with a great fundraising bonus.  People StyleWatch features a shiny gold “mirror” tote bag whose manufacturer, Galian, will donate 20% of proceeds to PHA on bags ordered at Galian.com by Aug. 16.  And, get a discount on the bag, too, by typing in PEOPLESTYLE20 at online checkout. 

So, this blog is not really about the honors, it's about the people who make them, and the awareness of PH they bring, happen.  People like those who initiated the Great NonProfit listing with their stories.  And, people like Jaclyne Franciscone who - when I wrote to say thank you - responded,
Absolutely! I’m thrilled it made it into the issue. Last February, after a three year struggle, I lost my mother to PH. I, along with my sister & dad, would do anything in our reach to help raise awareness for Pulmonary Hypertension. So happy I was able to make a small impact!     
Ripples in the stream.  Each of us makes a choice to act.  Each action makes a difference. 



  

Wednesday, July 10, 2013

The Bill is in...now it's up to you


Did you know that there is a bill in Congress dedicated to making life better for people with PH? It’s called the Pulmonary Hypertension Research and Diagnosis Act and was introduced by our friends Reps. Kevin Brady (R-TX) and Lois Capps (D-CA). Sen. Bob Casey (D-PA) is working on a Senate version to be introduced this month.

Some of you may be familiar with PH legislation from previous years, but our new bill is completely different. What's important about it in the current legislative environment is that it’s designed to make a big impact without asking the government to spend any new money.

The bill may be new, but its success still depends on you. Take a look at the guest post below from PHA’s Grassroots Campaigns Manager, Elisabeth Williams, to learn more.


PHers Educate Congress on New PH Legislation
Taking a stand together to advocate to Congress about PH is standing together to save a life.
We need more early diagnosis, more education in the medical field, more affordable treatments.”
                                                                                                             
                                                                                        --Nicole Cooper, PH patient


This spring, Reps. Kevin Brady (R-TX) and Lois Capps (D-CA) introduced a new bill called the PulmonaryHypertension Research and Diagnosis Act of 2013 (H.R. 2073) in the House of Representatives (H.R. 2073). Since then PHers have been emailing, calling and scheduling visits with their Members of Congress to educate them about how this bill will improve life for those living with pulmonary hypertension.

This budget neutral bill calls for the creation of a committee within the federal government focused on giving people living with PH longer, better lives. The group, including representatives from NIH, the Centers for Disease Control and the Department of Health and Human Services would work together to:
  • Advance the full spectrum of PH research from basic science to clinical trials
  • Increase early and accurate diagnosis of PH
  • Educate medical professionals and the public
So far, these efforts have resulted in several Members of Congress co-sponsoring the bill, including:

Rep. Timothy Bishop (D-NY)

Rep. Jim Costa (D-CA)

Rep. Peter King (R-NY)

Rep. Richard Neal (D-MA)

Del. Eleanor Holmes Norton (D-DC)

Rep. Devin Nunes (R-CA)

Rep. Peter Roskam (R-IL)
 

Stand Together and Advocate!

The success of this bill depends on you! Join other PHers who are standing together to push this bill through Congress. Here’s how:

1)      Contact Your Members of Congress! Educate your own Member of Congress and ask him or her to co-sponsor the newly introduced Pulmonary Hypertension Research and Diagnosis Act of 2013. It’s easy! Simply send an email using PHA’s new online advocacy tool. All you have to do is add your name and zip code and click on Take Action.  That will show you your Member of Congress. Then just take a few minutes to personalize the sample letter with your PH experience. With that brief effort you'll be maki9ng a big difference in helpong your Member of Congress understand the need for more treatments and early diagnosis.  (Oh, and if your Member of Congress is one of those listed above...change the sample letter to just say Thank You for supporting the Bill!)

2)      Sign up for the 435 Campaign! Stand with other PHers who are working to ensure that all 435 Members of Congress support legislation critical to the PH community. We’ll give you the tools to help you easily share your story and make PH more visible in Congress. Email Elisabeth at Advocacy@PHAssociation.org to join the 435 Campaign.

3)      Stay in the know! Stay up-to-date on late-breaking Congressional news and opportunities to advocate for PH legislation. Sign up for PHA’s monthly Advocacy in Action Alert emails

Wednesday, June 26, 2013

From fantasy to reality…and only 359 days, 4 hours and 42 minutes away


Once upon a time, a man came to a meeting and said, “We should organize an International PH Conference.”

That man was Ed Simpson, the husband of one of the four founders of PHA, and the year was 1992.  He spoke those words at the organization’s annual meeting which drew a total of 10 people.  He spoke them at a time when the entire treasury was $853.31.

Those words and the unlikely success of the meeting he proposed have changed the lives of thousands of people living with PH.  They have taken down the barriers between patients, caregivers and medical professionals and created knowledge, fellowship and partnerships that have made those fighting this rare disease stronger than could ever have been expected when they were spoken.

PHA’s International PH Conference and Scientific Sessions have grown to become the largest and most unique PH meeting in the world.  Like the disease, Conference is rare … being offered only once every two years.

We have now just crossed the midpoint between our 2012 Conference and PHA’s upcoming 2014 Conference.  As I write this, our Conference timer tells me we are 359 days, 4 hours and 42 minutes from banging the gavel to open Conference 2014.

Here are the basic facts…
              Theme: Racing Toward a Cure
              Dates: June 20 to 22, 2014
              Place: J.W. Marriott inIndianapolis Indiana

But Conference is so much more than a date and place.  If you’re a patient or family member, you can expect presentations from well over 100 medical professionals and many more from patients, caregivers and other experts. Many deep and continuing friendships are formed at Conference … you’ll have the opportunity to meet and connect with people living the same experience from throughout the U.S. and around the world.  Thirty nations were represented at Conference 2012.


If you’re a medical professional, you’ll have the chance to teach, learn and connect.  Virtually all the PH experts in the U.S. and many from other nations attend Conference for its stellar Scientific Sessions, its medical track and the opportunity to connect with patients and their families in very different ways.

You’ll be hearing much more about Conference in coming months - program, registration, special hotel rates and more - but here’s a summary video from a few years back.




Feel free to browse the  PHA You Tube Channel to find other Conference videos (and other interesting stuff) or check out a newsletter from a past Conference.

Thursday, May 23, 2013

Travels with Carl...#1

Tracy, Shelle, Carl, Wayne, Trudy, Joy, (in front)
Traci, Shelle, Carl, Wayne, Trudy, Joy (in front)
Since December, Carl Hicks has taken on a new responsibility for PHA - building our important new Chapter structure.  As he takes on considerable travel for this job, Carl has been taking that as an opportunity to connect with PHers around the country.  This is the first in an occasional series of guest blogs from Carl...

Starting a new practice of calling every special events organizer a few days before as well as after their event in order to be certain we’ve done our best to support them, I called Trudy Seidel. Trudy, one of our PAH patients had organized “Pray Phor a Cure,” a large, community-supported “garage sale” to be conducted in Vinton, Iowa, on May 4th. This was to be Trudy’s first event but instead of trepidation, (what I had with my first event), Trudy sounded ecstatic!

“We are doing so much more than a community garage sale,” she gushed, “we are having a silent auction as well as a live auction, and it has grown so large that we had to add another large building at the fairgrounds for the venue!” Continuing she said excitedly, “We have people coming from all over including from out-of-state, and I am so, so pumped!” I asked her if she minded if I dropped in, for after-all, I was in the neighborhood. Kinda, that is.  I was in Chicago for our Midwest Chapter’s first event that was scheduled for the very next day on Sunday, which put me a scant 275 miles away. I couldn’t think of a better way to spend a Saturday so, up at 4:00 AM, I launched across the prairies of Illinois for the farmland of north central Iowa in my little rental car.

Little zebras!
The GPS took me right to the Vinton Country Fairgrounds located in Vinton, a farm town of about 5,300 fine Americans. As I entered the door, it was readily apparent that most had donated something to Trudy’s cause, (your PHA), and most were there to provide the single mother of four all of their support. It also became once again apparent to me that our PH family extended to every corner of America as patients and caregivers I’d met during years of travel across the country began to exclaim, “There’s Carl! Carl is here!”

As my eyes became adjusted, coming in from the bright sunlight, I spotted Vern and Joy Gore, who’d flown in from Arizona the day previous to assist Trudy in her first event. All as Joy, a PH patient, battled PH AND cancer! There was Wayne Wilson (PH patient), and his wife, and Ginger Kahler, another patient who like Wayne was now confined to a scooter. Her big blue eyes welcoming, I’d collected my first of scores of hugs, less than 45 seconds into the door.

Zebras wherever we go...Sometimes it is PH
Next I encountered the “hostess of honor” herself, Trudy. She was effusive with happiness that I would drive out there to participate in her event, and so was I. The large room was abuzz with activity and everywhere I looked was evidence that a herd of zebras had thundered in off the savannah. Black and white stripes were in abundance whether it would be children exiting the face-painting activity to home- made posters that clearly depicted the importance of looking beyond the hoof beats.  It was so, so exciting and making it even more so was running into Shelle Goodwin, no-longer a PH patient, now in her fifth successful year past her double-lung transplant. That good news was dampened by seeing Merlin Krantz, a farmer in his seventies who’d recently lost his wife to PH. His comment to me was, “…she’s better off, I’m not.”

Tables were piled high with donated goods ranging from paintings to children’s clothing, tools, and fresh baked goods, lovingly prepared in our nation’s breadbasket. I decided to walk next door into the next building to see what items they had for sale in the live auction scheduled for noon. Smack in the middle of the doorway I literally ran into our own Traci Stewart, board member and Chair of PHA’s Pulmonary Hypertension Professional Network (PHPN). Wow, what a great surprise and an even greater hug!

Neatly arrayed next door awaiting the anxious bidders/ buyers were the items to be sold at live auction. At least eighty folding chairs were lined up in front of the auctioneer’s podium, which was to be ably manned by LeRoy Deutsch, a real auctioneer and Trudy’s father. Much to my surprise, every single one was filled and the walls were lined by those who’d come out to share in the struggle against PH. I thought how nice it was to see that outpouring of support and love for their neighbors and it reminded me of how rural Americans were once known to come far and wide to perform a barn-raising, banding together to make it happen. In the larger picture, that is what we are all doing in our PH PHamily across the country whether we are in bib-overalls and John Deere caps, pin-stripe suits or scrubs.

My biggest take-away from the weekend, in which Trudy raised more than $12,000 in her first event came from a discussion I overheard while there. One of the farmers in attendance sidled over to Trudy and asked, “What are you going to do with all this money, use it for your medical bills?” “No, Trudy replied, I’m going to give it to PHA. They can find the cure for it, and I can’t.”